The intersection of neuropsychology with digital technology, a.k.a teleneuropsychology, is revolutionizing the manner in which we assess cognition and function in children and adults. This change becomes especially relevant as the need for identifying subtle impairments and thereby finding effective treatments and interventions earlier in the life cycle is rapidly gaining acceptance. Digital technology encompasses various models of data collection including via virtual/remote assessments or hybrid assessments involving both in-clinic and virtual components. However, to more confidently apply teleneuropsychology in clinical practice, further research is required to evidence that in-clinic assessments are comparable to teleneuropsychological assessments. Teleneuropsychology also encompasses a host of devices including smartphones and novel methods of data collection including via speech. These novel methods and metrics need to validated across different settings and populations. This symposium, consisting of four abstracts, brings a balanced perspective of current and futuristic trends in our field. The first two abstracts address the current and urgent need to translate teleneuropsychology to clinical practice – the first abstract sheds light on the comparability of symptom and performance validity testing in adults tested in-person vs. by videoconferencing, while the second abstract evidences equivalency in pediatric cognitive measures using in-person vs. virtual formats. The last two abstracts focus on futuristic applications critical to move the field forward by focusing on speech acoustics that can be used to assess cognition – the third abstract suggests that speech metrics can be useful to distinguish among clinical groups, while the final abstract found that, despite differences in spoken languages, factor structure for speech acoustics is similar across two cultures, indicating relatively universal and low cost methods of harmonizing data.
Timothy Brearly, Penn State College of Medicine, Hershey, United States Paul Ingram, Texas Tech University, Lubbock, United States Ali Sapp, Texas Tech University, Lubbock, United States Robert Shura, VA Mid-Atlantic Mental Illness Research, Education, and Clinical Center, Salisbury, United States
Madeline Manning, Massachusetts General Hospital, Boston, United States Pieter Vuijk, Massachusetts General Hospital, Boston, United States Eline Laurent, Massachusetts General Hospital, Boston, United States Emmaline Cook, Massachusetts General Hospital, Boston, United States Ellen Braaten, Massachusetts General Hospital, Boston, United States Alysa Doyle, Massachusetts General Hospital, Boston, United States Mary Colvin, Massachusetts General Hospital, Boston, United States
David Libon, Rowan University, Stratrford, United States Rod Swenson, University of North Dakota School of Medicine and Health Sciences, Grand Forks, United States Russell Banks, Linus Health, Boston, United States Daniel Schulman, Linus Health, Boston, United States Sean Tobyne, Linus Health, Boston, United States Connor Higgins Higgins, Linus Health, Boston, United States Jeffrey Pobst, Linus Health, Boston, United States Claudio Toro-Serey, Linus Health, Boston, United States Stephanie Cosentino, Columbia University, New York, United States Catherine Price, University of Florida, Gainesville, United States
Preeti Sunderaraman, Boston University & Framingham Heart Study, Boston, United States Huitong Ding, Boston University, Boston, United States Cody Karjadi, Boston University & Framingham Heart Study, Boston, United States Jinying Chen, Boston University, Boston, United States James Glass, Massachusetts Institute of Technology, Cambridge, United States Spencer Low, Boston University, Boston, United States Sherral Devine, Boston University & Framingham Heart Study, Boston, United States Roshaslina Rosli, University of Malay, Kuala Lumpur, Malaysia Vijaya Kolachalama, Boston University, Boston, United States Honghuang Lin, Boston University, Boston, United States
